FI854035A0 - Farmaceutiska foereningar med antracyklinglykosider. - Google Patents

Farmaceutiska foereningar med antracyklinglykosider.

Info

Publication number
FI854035A0
FI854035A0 FI854035A FI854035A FI854035A0 FI 854035 A0 FI854035 A0 FI 854035A0 FI 854035 A FI854035 A FI 854035A FI 854035 A FI854035 A FI 854035A FI 854035 A0 FI854035 A0 FI 854035A0
Authority
FI
Finland
Prior art keywords
antacacyclinglykosider
particulars
pharmaceutical
pharmaceutical particulars
Prior art date
Application number
FI854035A
Other languages
English (en)
Other versions
FI854035L (fi
FI86252C (fi
FI86252B (fi
Inventor
Gaetano Gatti
Diego Oldani
Carlo Confalonieri
Luciano Gambini
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of FI854035A0 publication Critical patent/FI854035A0/fi
Publication of FI854035L publication Critical patent/FI854035L/fi
Application granted granted Critical
Publication of FI86252B publication Critical patent/FI86252B/fi
Publication of FI86252C publication Critical patent/FI86252C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI854035A 1984-10-22 1985-10-16 Foerfarande foer foerbaettring av en antracyklinglykosids upploesbarhet i en foer injektering laemplig loesningsmedelsblandning. FI86252C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8426672 1984-10-22
GB848426672A GB8426672D0 (en) 1984-10-22 1984-10-22 Pharmaceutical compositions

Publications (4)

Publication Number Publication Date
FI854035A0 true FI854035A0 (fi) 1985-10-16
FI854035L FI854035L (fi) 1986-04-23
FI86252B FI86252B (fi) 1992-04-30
FI86252C FI86252C (fi) 1992-08-10

Family

ID=10568553

Family Applications (2)

Application Number Title Priority Date Filing Date
FI853913A FI853913A (fi) 1984-10-22 1985-10-08 Farmaceutiska foereningar som antracyklinglykosider.
FI854035A FI86252C (fi) 1984-10-22 1985-10-16 Foerfarande foer foerbaettring av en antracyklinglykosids upploesbarhet i en foer injektering laemplig loesningsmedelsblandning.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI853913A FI853913A (fi) 1984-10-22 1985-10-08 Farmaceutiska foereningar som antracyklinglykosider.

Country Status (35)

Country Link
US (4) US4675311A (fi)
JP (1) JPH0611700B2 (fi)
KR (1) KR920005813B1 (fi)
CN (1) CN85107562B (fi)
AT (1) AT401345B (fi)
AU (1) AU572003B2 (fi)
BE (1) BE903484A (fi)
BG (1) BG60934B2 (fi)
CA (1) CA1248453A (fi)
CH (1) CH667594A5 (fi)
CS (1) CS270421B2 (fi)
DE (1) DE3536896C2 (fi)
DK (1) DK165620C (fi)
ES (1) ES8605374A1 (fi)
FI (2) FI853913A (fi)
FR (1) FR2571966B1 (fi)
GB (2) GB8426672D0 (fi)
GR (1) GR852549B (fi)
HK (1) HK94390A (fi)
HU (1) HU197988B (fi)
IE (1) IE56992B1 (fi)
IL (1) IL76732A (fi)
IT (1) IT1186779B (fi)
MY (1) MY103956A (fi)
NL (1) NL191308C (fi)
NO (1) NO170616C (fi)
NZ (1) NZ213885A (fi)
PH (1) PH23982A (fi)
PT (1) PT81347B (fi)
RU (2) RU1836088C (fi)
SE (1) SE467520B (fi)
SG (1) SG80290G (fi)
UA (2) UA34419C2 (fi)
YU (1) YU46160B (fi)
ZA (1) ZA858033B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977082A (en) * 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
ES2039460T3 (es) * 1986-12-05 1993-10-01 Farmitalia Carlo Erba S.R.L. Un procedimiento para producir una solucion inyectable de glicosido de antraciclina.
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
US6300361B1 (en) 1990-07-25 2001-10-09 Novartis Ag Stabilized pharmaceutical compositions comprising acid donors
WO1998029110A2 (en) 1996-12-30 1998-07-09 Battelle Memorial Institute Formulation and method for treating neoplasms by inhalation
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid
DE60321450D1 (de) 2002-02-22 2008-07-17 Schering Corp Pharmazeutische zubereitungen von antineoplastischen wirkstoffen, insbesondere temozolomid, verfahren zu ihrer herstellung und deren verwendung
EP1474995B1 (en) * 2003-05-06 2012-11-14 Gumlink A/S A method for producing chewing gum granules, a gum composition extruder and granulating system, and a chewing gum product
WO2005004805A2 (en) * 2003-07-02 2005-01-20 Solux Corporation Thermally stable crystalline epirubicin hydrochloride and method of making the same
US20090099346A1 (en) * 2003-07-02 2009-04-16 Victor Matvienko Thermally stable crystalline epirubicin hydrochloride
ES2425083T3 (es) * 2003-09-25 2013-10-11 Astellas Pharma Inc. Agente antitumoral que comprende FK228 como inhibidor de histona desacetilasa y doxorrubicina como inhibidor de topoisomerasa II
US7388083B2 (en) * 2005-03-07 2008-06-17 Solux Corporation Epimerization of 4′-C bond and modification of 14-CH3-(CO)-fragment in anthracyclin antibiotics
EP1814525A2 (en) * 2005-05-11 2007-08-08 Sicor Inc. Stable lyophilized anthracycline glycosides
WO2007011743A2 (en) 2005-07-14 2007-01-25 Lipothera, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
US9035032B2 (en) * 2005-12-13 2015-05-19 Solux Corporation Method for preparing 4-demethyldaunorubicin
US8802830B2 (en) * 2005-12-20 2014-08-12 Solux Corporation Synthesis of epirubicin from 13-dihydrodaunorubicine
US8148338B2 (en) * 2006-02-22 2012-04-03 Supratek Pharma Inc. Doxorubicin formulations for anti-cancer use
US7470672B2 (en) * 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
JP5634862B2 (ja) * 2007-05-16 2014-12-03 カーテーベー トゥモーアフォルシュングス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低粘度アントラサイクリン製剤
ES2439497T3 (es) * 2007-09-04 2014-01-23 Meiji Seika Pharma Co., Ltd. Preparación de una inyección, de una solución para inyección y de un kit de inyección
KR20100058662A (ko) * 2007-10-26 2010-06-03 화이자 프로덕츠 인코포레이티드 개에게서 림프종을 치료하기 위한 이다루비신
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
SG182485A1 (en) * 2010-01-15 2012-08-30 Lithera Inc Lyophilized cake formulations
CN103269693A (zh) 2010-11-24 2013-08-28 利赛拉公司 选择性、亲脂性及长效型β激动剂单一治疗调配物和用于肥胖及外形凸起的美容治疗的方法
DE102011103751A1 (de) 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
DE102011111991A1 (de) * 2011-08-30 2013-02-28 Lead Discovery Center Gmbh Neue Cyclosporin-Derivate
EP3915369A1 (en) 2012-12-13 2021-12-01 CytRx Corporation Anthracycline formulations
NZ631022A (en) 2013-06-05 2018-05-25 Cytrx Corp Cytotoxic agents for the treatment of cancer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
GB1506200A (en) * 1975-04-30 1978-04-05 Farmaceutici Italia Glycosides
GB1567456A (en) * 1976-11-16 1980-05-14 Farmaceutici Italia Daunomycin derivatives
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
JPS563851A (en) * 1979-06-22 1981-01-16 Matsushita Electric Works Ltd Fireplace in floor
JPS5756494A (en) * 1980-09-22 1982-04-05 Microbial Chem Res Found New anthracyclin derivative
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
IT1210476B (it) * 1981-05-28 1989-09-14 Erba Farmitalia Antracicline.
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
FI75834C (fi) * 1982-05-24 1988-08-08 Erba Farmitalia Foerfarande foer framstaellning av antracyklinglykosidfoereningar.
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
CA1248944A (en) * 1982-09-28 1989-01-17 Gareth J. Thomas Anthracycline glycosides
JPS5982395A (ja) * 1982-11-02 1984-05-12 Microbial Chem Res Found アントラサイクリン化合物、その製造法およびその用途
GR79729B (fi) * 1982-12-20 1984-10-31 Univ Ohio State Res Found
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
US4537882A (en) * 1984-05-10 1985-08-27 Ohio State University 4-Demethoxy-3'-desamino-2'-halo-anthracycline and pharmaceutical composition containing same

Also Published As

Publication number Publication date
BE903484A (fr) 1986-04-21
DK165620B (da) 1992-12-28
RU2101018C1 (ru) 1998-01-10
CA1248453A (en) 1989-01-10
FI854035L (fi) 1986-04-23
MY103956A (en) 1993-10-30
CS270421B2 (en) 1990-06-13
GB8525709D0 (en) 1985-11-20
FR2571966A1 (fr) 1986-04-25
JPH0611700B2 (ja) 1994-02-16
RU1836088C (ru) 1993-08-23
GB8426672D0 (en) 1984-11-28
IT1186779B (it) 1987-12-16
SG80290G (en) 1990-11-23
SE8504945D0 (sv) 1985-10-21
NO170616C (no) 1992-11-11
US4840938A (en) 1989-06-20
KR860003014A (ko) 1986-05-19
NL191308C (nl) 1995-05-16
DK481585A (da) 1986-04-23
DK165620C (da) 1993-06-01
US4675311A (en) 1987-06-23
IT8522507A0 (it) 1985-10-16
ES8605374A1 (es) 1986-03-16
PT81347B (pt) 1987-11-11
UA19169A (uk) 1997-12-25
BG60934B2 (bg) 1996-06-28
NO854194L (no) 1986-04-23
NL8502869A (nl) 1986-05-16
HUT40759A (en) 1987-02-27
CS756585A2 (en) 1989-11-14
CH667594A5 (de) 1988-10-31
HK94390A (en) 1990-11-23
US5091372A (en) 1992-02-25
FI86252C (fi) 1992-08-10
GR852549B (fi) 1986-02-24
GB2165751B (en) 1988-08-17
IE852593L (en) 1986-04-22
ZA858033B (en) 1986-06-25
US5091373A (en) 1992-02-25
PT81347A (en) 1985-11-01
FI853913A (fi) 1986-04-23
ATA303285A (de) 1996-01-15
IE56992B1 (en) 1992-02-26
HU197988B (en) 1989-07-28
YU46160B (sh) 1993-05-28
SE8504945L (sv) 1986-04-23
DE3536896A1 (de) 1986-04-24
GB2165751A (en) 1986-04-23
IL76732A (en) 1989-07-31
YU164485A (en) 1987-10-31
CN85107562A (zh) 1986-07-23
SE467520B (sv) 1992-08-03
NL191308B (nl) 1994-12-16
FR2571966B1 (fr) 1988-04-15
ES547578A0 (es) 1986-03-16
AU4880585A (en) 1986-05-01
JPS61246129A (ja) 1986-11-01
AT401345B (de) 1996-08-26
AU572003B2 (en) 1988-04-28
CN85107562B (zh) 1988-06-01
PH23982A (en) 1990-02-09
UA34419C2 (uk) 2001-03-15
NZ213885A (en) 1988-05-30
DK481585D0 (da) 1985-10-21
FI86252B (fi) 1992-04-30
KR920005813B1 (ko) 1992-07-20
IL76732A0 (en) 1986-02-28
FI853913A0 (fi) 1985-10-08
NO170616B (no) 1992-08-03
DE3536896C2 (de) 1996-11-14

Similar Documents

Publication Publication Date Title
FI854035A0 (fi) Farmaceutiska foereningar med antracyklinglykosider.
MX9202933A (es) Derivados de tiazolidindiona.
FI863077A (fi) Farmaceutisk dosenhet.
FI854573A0 (fi) Farmaceutiska kapslar med foerdroejd frigoering.
FI860447A (fi) Foerfarande foer behandling av luftpermeabla underlag med skum.
FI862544A (fi) Kretssystem foer modifiering av dynamisk baervidd med anvaendning av verkningssubstitutions- och superponeringsteknik.
FI862393A (fi) Silanordning med anordning foer reduktion av rejekt.
FI861186A0 (fi) Foerbaettringar av anordningar foer framstaellning av mineralfibrer med hjaelp av centrifugalhjul.
DK288686D0 (da) Farmaceutiske praeparater
IT1209615B (it) Composizione farmaceutica
FI852658A0 (fi) Farmaceutiska aemnen.
MX9203229A (es) Derivados de lankacidina.
FI852772L (fi) Formsten.
FI862338A (fi) Foerfarande foer vaord av haor med trialkylaettiksyraamider.
FI863883A (fi) Anordning foer tillslutning av flaskhals.
DK453785D0 (da) Laegemiddel med grf-virkning
FI853523A0 (fi) Foerfarande foer utfoering av immunobestaemningar med hjaelp av enzymstaempel.
FI852876L (fi) Anordning foer undervattensarbete.
FI862472A (fi) Ampullhaollare med en luftoeppning foer reducering av statisk elektricitet.
RO90578A2 (ro) Produs medicamentos fitoterapeutic hepatoprotector
SE8404468D0 (sv) Farmaceutisk beredning
DK324587A (da) Transdermalt farmaceutisk praeparat
FI831109A0 (fi) Med vaogenergi fungerande pumpanordning
FI870539A (fi) Foerfarande foer aoterstaellning av komponenter med kroekt form.
BR6401611U (pt) Colchao medicinal

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: PHARMACIA & UPJOHN S.P.A.

PC Transfer of assignment of patent

Owner name: PHARMACIA & UPJOHN S.P.A.

FG Patent granted

Owner name: PHARMACIA ITALIA S.P.A.

MA Patent expired